Related Experiment Video
Updated: Jun 15, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis
Seo Young Kim1, James P Guevara, Kyoung Mi Kim
1Brigham and Women's Hospital, Boston, Massachusetts, USA. skim62@partners.org
Insights
High uric acid levels (hyperuricemia) may slightly increase coronary heart disease (CHD) risk, particularly in women. Further research is needed to understand this association and its implications for cardiovascular disease prevention.
Area of Science:
- Cardiology
- Metabolic Health
- Epidemiology
Background:
- Serum uric acid's role in cardiovascular disease (CVD) is debated.
- Hyperuricemia is linked to conditions like coronary heart disease (CHD), stroke, and hypertension.
Purpose of the Study:
- To systematically review and meta-analyze the risk of CHD associated with hyperuricemia in adults.
- To determine if hyperuricemia is an independent risk factor for CHD.
Main Methods:
- Systematic review and random-effects meta-analysis of prospective cohort studies.
- Searched major electronic databases for studies on hyperuricemia and CHD (through February 2009).
- Included studies with data on CHD incidence or mortality related to serum uric acid levels.
Main Results:
- Analyzed 26 studies involving 402,997 adults.
- Hyperuricemia showed an association with increased CHD incidence and mortality.
- Adjusted analysis revealed a pooled RR of 1.09 for CHD incidence and 1.16 for CHD mortality.
- Each 1 mg/dl increase in uric acid correlated with a 1.12 RR for CHD mortality.
- Found no significant association in men, but increased CHD mortality risk in women (RR 1.67).
Conclusions:
- Hyperuricemia may marginally increase CHD risk, independent of traditional risk factors.
- The increased risk of CHD mortality in women warrants further investigation.
- Highlights the potential importance of monitoring uric acid levels for cardiovascular health, especially in women.
Objective:
The role of serum uric acid as an independent risk factor for cardiovascular disease remains unclear, although hyperuricemia is associated with cardiovascular disease such as coronary heart disease (CHD), stroke, and hypertension.
Methods:
A systematic review and meta-analysis using a random-effects model was conducted to determine the risk of CHD associated with hyperuricemia in adults. Studies of hyperuricemia and CHD were identified by searching major electronic databases using the medical subject headings and keywords without language restriction (through February 2009). Only prospective cohort studies were included if they had data on CHD incidences or mortalities related to serum uric acid levels in adults.
Results:
Twenty-six eligible studies of 402,997 adults were identified. Hyperuricemia was associated with an increased risk of CHD incidence (unadjusted risk ratio [RR] 1.34, 95% confidence interval [95% CI] 1.19-1.49) and mortality (unadjusted RR 1.46, 95% CI 1.20-1.73). When adjusted for potential confounding, the pooled RR was 1.09 (95% CI 1.03-1.16) for CHD incidence and 1.16 (95% CI 1.01-1.30) for CHD mortality. For each increase of 1 mg/dl in uric acid level, the pooled multivariate RR for CHD mortality was 1.12 (95% CI 1.05-1.19). Subgroup analyses showed no significant association between hyperuricemia and CHD incidence/mortality in men, but an increased risk for CHD mortality in women (RR 1.67, 95% CI 1.30-2.04).
Conclusion:
Hyperuricemia may marginally increase the risk of CHD events, independently of traditional CHD risk factors. A more pronounced increased risk for CHD mortality in women should be investigated in future research.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Hypertension III: Clinical Manifestations and Diagnostic Studies